Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113735894B details a Cr-catalyzed route to chiral 2,3-allenols. Offers high enantioselectivity and scalable conditions for API intermediates.
Novel organocatalytic route for bicyclic proline esters. Enhances purity and scalability for API manufacturing. Cost-effective intermediate production.
Patent CN103038242B details novel Ru complexes for asymmetric hydrogenation. Offers improved reactivity and supply chain stability for fine chemical manufacturing partners.
Patent CN111217844B details a cost-effective 1,1-diboronation of olefins using Cp2ZrCl2. This method offers high atom economy and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN105085426A reveals high-yield nickel-copper catalyzed synthesis. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116041216A reveals a high-yield Pd-catalyzed asymmetric C-H arylation method. This breakthrough offers reliable pharmaceutical intermediate suppliers a scalable route for chiral amides with superior enantioselectivity.
Patent CN114773294A reveals a metal-free route for ebselen compounds. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN111690009A discloses novel Co/Fe complexes for high-ee hydrogenation of alpha-silyl styrenes, offering cost-effective pharma intermediate synthesis.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.
Novel quinine-catalyzed route for chiral sulfinamides. High purity, mild conditions, scalable for pharma intermediates. Reliable supply chain solutions.
Patent CN110028518B details a green catalytic route for pyrano[2,3-d]pyrimidone derivatives, offering high purity and recyclable catalysts for reliable pharmaceutical intermediate supply chains.
Patent CN107629051B reveals a novel three-step carbonylation route for evodiamine, offering streamlined production and cost advantages for pharmaceutical intermediates.
Patent CN107922305A details a novel one-pot Sonogashira coupling using fluorosulfonates, offering significant cost reduction and supply chain reliability for high-purity aromatic compounds.
Discover the novel 4-step synthesis of Montelukast Sodium intermediate via patent CN115710221A. Achieve high purity, reduced costs, and scalable supply chain solutions.
Novel copper-rhenium catalyst method for aryl ketones. High yield synthesis reduces costs and ensures supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN112321628A reveals a green water-based copper catalytic method for beta-silyl nitriles, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN109499618B reveals a green gas-phase oxidation catalyst for benzoylformic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing and zero waste discharge.
Patent CN112266364B reveals metal-free hydrogenation for tetrahydroquinoxaline. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing without transition metals.
Patent CN102850314B enables aqueous ionic liquid catalysis for benzoxanthene derivatives ensuring high purity and scalable environmentally friendly manufacturing processes for global supply chains.
Patent CN116768938B reveals iron catalyst technology for Rimegepant intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.